ALFA News
Straight from the exchange filing
Every announcement Morepen Laboratories has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Morepen Laboratories announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Morepen Laboratories reports 117.4% YoY net profit growth to ₹88.9 crore in Q2 FY27. Revenue surged 81% to ₹746 crore with operating margins at 15.4%.
Morepen Laboratories reaches 614 KL reactor capacity following the completion of its Phase 1 expansion ahead of schedule, targeting API and CDMO growth.
